VICKS BLUE THROAT DROPS 0.3% .3 %
MENTHOL : .3 % · DIN 01955330 · PROCTER & GAMBLE INC
Health Canada status: CANCELLED POST MARKET
What is VICKS BLUE THROAT DROPS 0.3%?
VICKS BLUE THROAT DROPS 0.3% .3 % contains MENTHOL : .3 %. It is listed in the Health Canada Drug Product Database under DIN 01955330, held by PROCTER & GAMBLE INC, supplied as LOZENGE for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 04-Aug-1999. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 01955330 |
|---|---|
| Brand name | VICKS BLUE THROAT DROPS 0.3% |
| Generic / active ingredient | MENTHOL : .3 % |
| Manufacturer | PROCTER & GAMBLE INC |
| Strength | .3 % |
| Dosage form | LOZENGE |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | R02AA20 VARIOUS |
| AHFS class | 52:92.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 04-Aug-1999 |
| Original market date | 1992-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code R02AA20 VARIOUS. 1 of 8 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| NEO-LARYNGOBIS | 135 MG | SUPPOSITORY | TEVA CANADA LIMITED | MARKETED | DIN 00065927 |
| ARKODYNE | 3 MG | LOZENGE | LABORATOIRE ROMILO | CANCELLED POST MARKET | DIN 00520187 |
| BENTASIL EXTRA STRENGTH MENTHOL | 5.2 MG | LOZENGE | CARTER-HORNER CORP. | CANCELLED POST MARKET | DIN 02248462 |
| BIONET LOZENGE | 7.5 MG | LOZENGE | CHURCH & DWIGHT CANADA CORP | CANCELLED POST MARKET | DIN 00116785 |
| LARYNSOL LOZ | .6 MG | LOZENGE | HERBES UNIVERSELLES INC. | CANCELLED POST MARKET | DIN 00444758 |
| MEGGEZONES MENTHOL PASTILLES | 17.3 MG | LOZENGE | SCHERING-PLOUGH CANADA INC | CANCELLED POST MARKET | DIN 01909762 |
| NEO LARYNGOBIS ENF | 67.5 MG | SUPPOSITORY | LAB BIO CHIMIQUE INC.,DIVISION OF TECHNILAB PHARMA INC. | CANCELLED POST MARKET | DIN 00065919 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.